MRL Ventures Fund Investor

MRL Ventures is Merck’s independent early-stage therapeutics venture capital fund.

Founded Date: 2014-01-01
Investor Type: Corporate Venture Capital, Venture Capital
Funding Status: Series A
Total Funding: 18735034
Employee Number: 1-10
Headquarters: Cambridge, Massachusetts, United States
Last Funding Date: 2018-05-23
Last Funding Type: Series A
Estimated Revenue: $1M to $10M
Investment Stage: Convertible Note, Early Stage Venture, Seed, Venture
Number Of Exists: 11
Industry: Biomarkers Discovery